peptides research FAQ

Document baseline biological age markers before starting any peptide protocol. Without pre-treatment measurements of inflammatory markers, skin elasticity, or epigenetic age, you can't differentiate peptide effects from placebo or lifestyle confounders. Research facilities use baseline assessment as the control—subjective improvements without biomarker changes indicate non-specific effects. Schedule blood work (CRP, IL-6, IGF-1) and dermal elasticity measurement within two weeks before first administration.

Verify three factors: peptide source quality, storage integrity, and baseline biological state. If you sourced peptides from an unverified compounding facility, the amino acid sequence may not match the label—this is disturbingly common in the peptide market. If storage wasn't maintained at 2–8°C throughout, denaturation nullified the dose. If your baseline inflammatory markers were already low (CRP <1.0 mg/L), there's limited room for improvement—peptides restore declining function, they don't enhance optimal function.

Use a medical-grade cooling system that maintains 2–8°C for the entire transit period. Standard ice packs and insulated lunch bags do not provide reliable temperature control beyond 6–8 hours. FRIO wallets use evaporative cooling to maintain 18–26°C without refrigeration, but this exceeds the safe storage range for reconstituted peptides. Purpose-built insulin coolers with gel packs maintain 2–8°C for 36–48 hours if pre-chilled properly. If you cannot guarantee temperature control for the full travel duration, do not transport reconstituted peptides. Bring lyophilized vials and reconstitute on-site instead.

This reflects receptor downregulation and homeostatic adaptation, not peptide degradation. Ghrelin receptors desensitize with chronic stimulation, reducing pulsatile GH response even at consistent doses. Research protocols address this through cycling: 8 weeks on, 4 weeks off allows receptor density to normalize. Alternatively, rotating between different GH secretagogues. Switching from ipamorelin to MK 677 mid-study. Prevents single-receptor desensitization. Do not increase dose to overcome the plateau. This accelerates downregulation without restoring the original response magnitude.

Discard it immediately. Cloudiness indicates protein aggregation from improper lyophilization, contamination, or temperature excursion during storage. Aggregated peptides have reduced bioavailability and altered immunogenicity. Injecting them produces unpredictable results and introduces variables that confound your research data. Properly reconstituted peptides should form a clear, colorless solution within 30 seconds. If dissolution takes longer or produces particulates, the peptide has degraded before reconstitution. This is why sourcing from facilities with verified cold-chain logistics matters. A single shipping delay in summer heat can destroy an entire batch.